August 04, 2022
Voyager Therapeutics
Voyager Therapeutics Prioritizes Pipeline and Reports Second Quarter 2022 Financial and Operating Results
August 04, 2022
Magenta Therapeutics
Magenta Therapeutics Reports Second Quarter Financial Results and Recent Program Highlights
August 03, 2022
Voyager Therapeutics
Voyager Therapeutics Presents New Data Demonstrating Novel Candidate Therapeutic Antibodies Reduced Tau Pathology in Multiple Preclinical Models
August 03, 2022
Nurix
Nurix Therapeutics Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer
August 02, 2022
Element Science
Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)